258 related articles for article (PubMed ID: 11698588)
1. Exogenous anandamide protects rat brain against acute neuronal injury in vivo.
van der Stelt M; Veldhuis WB; van Haaften GW; Fezza F; Bisogno T; Bar PR; Veldink GA; Vliegenthart JF; Di Marzo V; Nicolay K
J Neurosci; 2001 Nov; 21(22):8765-71. PubMed ID: 11698588
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
Veldhuis WB; van der Stelt M; Wadman MW; van Zadelhoff G; Maccarrone M; Fezza F; Veldink GA; Vliegenthart JF; Bär PR; Nicolay K; Di Marzo V
J Neurosci; 2003 May; 23(10):4127-33. PubMed ID: 12764100
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity.
van der Stelt M; Veldhuis WB; Bär PR; Veldink GA; Vliegenthart JF; Nicolay K
J Neurosci; 2001 Sep; 21(17):6475-9. PubMed ID: 11517236
[TBL] [Abstract][Full Text] [Related]
4. Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth.
Bifulco M; Laezza C; Portella G; Vitale M; Orlando P; De Petrocellis L; Di Marzo V
FASEB J; 2001 Dec; 15(14):2745-7. PubMed ID: 11687506
[TBL] [Abstract][Full Text] [Related]
5. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
6. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
[TBL] [Abstract][Full Text] [Related]
7. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
8. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease.
Di Marzo V; Hill MP; Bisogno T; Crossman AR; Brotchie JM
FASEB J; 2000 Jul; 14(10):1432-8. PubMed ID: 10877836
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats.
Manduca A; Morena M; Campolongo P; Servadio M; Palmery M; Trabace L; Hill MN; Vanderschuren LJ; Cuomo V; Trezza V
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1362-74. PubMed ID: 25914159
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.
Helyes Z; Németh J; Thán M; Bölcskei K; Pintér E; Szolcsányi J
Life Sci; 2003 Sep; 73(18):2345-53. PubMed ID: 12941436
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoids control spasticity in a multiple sclerosis model.
Baker D; Pryce G; Croxford JL; Brown P; Pertwee RG; Makriyannis A; Khanolkar A; Layward L; Fezza F; Bisogno T; Di Marzo V
FASEB J; 2001 Feb; 15(2):300-2. PubMed ID: 11156943
[TBL] [Abstract][Full Text] [Related]
12. Mesenteric vasodilation mediated by endothelial anandamide receptors.
Wagner JA; Varga K; Járai Z; Kunos G
Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the endocannabinoid system in human neuronal cells and proteomic analysis of anandamide-induced apoptosis.
Pasquariello N; Catanzaro G; Marzano V; Amadio D; Barcaroli D; Oddi S; Federici G; Urbani A; Finazzi Agrò A; Maccarrone M
J Biol Chem; 2009 Oct; 284(43):29413-26. PubMed ID: 19690173
[TBL] [Abstract][Full Text] [Related]
14. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
Pratt PF; Hillard CJ; Edgemond WS; Campbell WB
Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889
[TBL] [Abstract][Full Text] [Related]
15. Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinol.
Costa B; Colleoni M
Eur J Pharmacol; 2000 Apr; 395(1):1-7. PubMed ID: 10781666
[TBL] [Abstract][Full Text] [Related]
16. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.
González S; Cascio MG; Fernández-Ruiz J; Fezza F; Di Marzo V; Ramos JA
Brain Res; 2002 Nov; 954(1):73-81. PubMed ID: 12393235
[TBL] [Abstract][Full Text] [Related]
17. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
[TBL] [Abstract][Full Text] [Related]
18. Anandamide Reduces the Toxic Synergism Exerted by Quinolinic Acid and Glutaric Acid in Rat Brain Neuronal Cells.
Kotlar I; Rangel-López E; Colonnello A; Aguilera-Portillo G; Serratos IN; Galván-Arzate S; Pedraza-Chaverri J; Túnez I; Wajner M; Santamaría A
Neuroscience; 2019 Mar; 401():84-95. PubMed ID: 30668975
[TBL] [Abstract][Full Text] [Related]
19. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors.
Bisogno T; MacCarrone M; De Petrocellis L; Jarrahian A; Finazzi-Agrò A; Hillard C; Di Marzo V
Eur J Biochem; 2001 Apr; 268(7):1982-9. PubMed ID: 11277920
[TBL] [Abstract][Full Text] [Related]
20. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.
Darmani NA
J Pharmacol Exp Ther; 2002 Jan; 300(1):34-42. PubMed ID: 11752094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
